Dissemination of a bla VIM-2-carrying integron among enterobacteriaceae species in Mexico: Report from the SENTRY antimicrobial surveillance program

Microbial Drug Resistance

Volumn 15, Issue 1, 2009, Pages 33-35

  Morfin Otero, Rayo ^a   Rodriguez Noriega, Eduardo ^a   Deshpande, Lalitagauri M ^b   Sader, Helio S ^b   Castanheira, Mariana ^b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b JMI LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; INTEGRON; KLEBSIELLA OXYTOCA; MEXICO; NONHUMAN; PLASMID; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENES, BACTERIAL; HOSPITALS; HUMANS; INTEGRONS; KLEBSIELLA OXYTOCA; MEXICO; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POPULATION SURVEILLANCE;

ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; KLEBSIELLA OXYTOCA;

EID: 66749190042     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2009.0878     Document Type: Article

References (9)

1. VIM-7 carbapenemase-producing Pseudomonas aerugi-nosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC Program. J. Clin. Microbiol. 45:614-615.
2. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement, M100-S18. CLSI, Wayne, PA.
3. IMP-15, in a class 1 integron (In95) from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob. Agents Chemother. 52:2943-2946.
4. Garza-Ramos, U., P. Tinoco, J. Silva-Sanchez, R. Morfin-Otero, E. Rodriguez-Noriega, G. Leon-Garnica, H.S. Sader, and R.N. Jones. 2008. Metallo-β-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico. Int. J. Antimicrob. Agents 31:78-80.
5. Hanson, N.D., A. Hossain, L. Buck, E.S. Moland, and K.S. Thomson. 2006. First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-β-lactamase, IMP-18. Antimicrob. Agents Chemother. 50: 2272-2273.
6. Lolans, K., T.W. Rice, L.S. Munoz-Price, and J.P. Quinn. 2006. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob. Agents Chemother. 50:2941-2945.
7. Martin, C.A., K. Morita, J.A. Ribes, L.M. Deshpande, H.S. Sader, and M. Castanheira. 2008. IMP-15-producing Pseudomonas aeruginosa isolated in a United States medical center: a recent arrival from Mexico. Antimicrob. Agents Chemother. 52:2289-2290.
8. Pitout, J.D., D.B. Gregson, L. Poirel, J.A. McClure, P. Le, and D.L. Church. 2005. Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J. Clin. Microbiol. 43:3129-3135.
9. Walsh, T.R., M.A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.